News | May 07, 2026
Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum
The standout story remains Wegovy, particularly its new oral formulation
The standout story remains Wegovy, particularly its new oral formulation
The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness
FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
Subscribe To Our Newsletter & Stay Updated
